You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR ORAMORPH SR


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ORAMORPH SR

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02556970 ↗ A Study Investigating Pain Following Single-port or Multi-port Video Assisted Thoracoscopic Surgery Withdrawn David Telling Charitable Trust N/A 1969-12-31 This study seeks to establish if thoracoscopic surgery performed through a single port or incision reduces early post-operative pain compared with conventional multiple port thoracoscopic surgery. This initial pilot study is designed to establish whether a trial of the two techniques is acceptable to patients, clinically feasible and can be delivered in a reasonable timescale.
NCT02556970 ↗ A Study Investigating Pain Following Single-port or Multi-port Video Assisted Thoracoscopic Surgery Withdrawn University Hospitals Bristol and Weston NHS Foundation Trust N/A 1969-12-31 This study seeks to establish if thoracoscopic surgery performed through a single port or incision reduces early post-operative pain compared with conventional multiple port thoracoscopic surgery. This initial pilot study is designed to establish whether a trial of the two techniques is acceptable to patients, clinically feasible and can be delivered in a reasonable timescale.
NCT02556970 ↗ A Study Investigating Pain Following Single-port or Multi-port Video Assisted Thoracoscopic Surgery Withdrawn University Hospitals Bristol NHS Foundation Trust N/A 1969-12-31 This study seeks to establish if thoracoscopic surgery performed through a single port or incision reduces early post-operative pain compared with conventional multiple port thoracoscopic surgery. This initial pilot study is designed to establish whether a trial of the two techniques is acceptable to patients, clinically feasible and can be delivered in a reasonable timescale.
NCT02869321 ↗ Analgesic Efficacy of Transmucosal Fentanyl for Breakthrough Pain Caused by Interventional Gastrostomy Completed Central Hospital, Nancy, France Phase 4 2015-05-01 Patients with Head & Neck Squamous Cell Carcinoma often need a gastrostomy. It can be performed with a radiological approach. This procedure is usually not performed under general anesthesia, but local anesthesia is not sufficient to counteract pain due to gastric insufflation and incision of the abdominal wall. Standard analgesic treatments are usually not well-fitted due to onset of action or route of administration. An alternative solution could be fentanyl nasal spray, a treatment with a fast onset of action and with easy use allowing repetition if needed, during the procedure. The purpose of this study is to compare analgesic efficacy of nasal instillation of PECFENT® to usually administered morphinic analgesic treatment with fast onset of action (ORAMORPH®), in radiologic percutaneous gastrostomy tube placement: - during the procedure - following the procedure (measured by Visual Analog Scale (VAS) for Pain at 15 min, 30 min, 1 hour, 2 hours, 3 hours, 4 hours, 6 hours and 12 hours after procedure). Secondary purposes are to compare easiness of 2 treatments and their adverse effects.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ORAMORPH SR

Condition Name

Condition Name for ORAMORPH SR
Intervention Trials
Malignant Neoplasm 1
Malignant Solid Neoplasm 1
Metastatic Malignant Neoplasm 1
Metastatic Malignant Solid Neoplasm 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ORAMORPH SR
Intervention Trials
Pain, Postoperative 1
Neoplasms, Second Primary 1
Neoplasms 1
Head and Neck Neoplasms 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ORAMORPH SR

Trials by Country

Trials by Country for ORAMORPH SR
Location Trials
United States 1
France 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ORAMORPH SR
Location Trials
Texas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ORAMORPH SR

Clinical Trial Phase

Clinical Trial Phase for ORAMORPH SR
Clinical Trial Phase Trials
Phase 4 1
N/A 1
Early Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ORAMORPH SR
Clinical Trial Phase Trials
Withdrawn 1
Active, not recruiting 1
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ORAMORPH SR

Sponsor Name

Sponsor Name for ORAMORPH SR
Sponsor Trials
David Telling Charitable Trust 1
University Hospitals Bristol and Weston NHS Foundation Trust 1
University Hospitals Bristol NHS Foundation Trust 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ORAMORPH SR
Sponsor Trials
Other 5
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.